The National Institutes of Health (NIH) is funding the first-ever, long-term study to research the impacts of medical marijuana on opioid use.
The NIH has awarded a five-year $3.8 million grant to researchers at Albert Einstein College of Medicine and Montefiore Health System to study whether medical marijuana reduces opioid use among adults with chronic pain, including people with HIV.
Check out: Marijuana industry could be worth $50 billion annually by 2026
Also see: Opioids are ravaging the U.S., but they’re still the best pain drug we’ve got
“There is a lack of information about the impact of medical marijuana on opioid use in those with chronic pain,” said Dr. Chinazo Cunningham, associate chief of internal medicine at Einstein and Montefiore, in a statement. “We hope this study will fill in the gaps and provide doctors and patients with some much needed guidance.”
The study comes in the midst of